|FDA approves Astellas' NDA for Cresemba to treat zygomycosis|
The US Food and Drug Administration (FDA) has approved Astellas' New Drug Application (NDA) for the use of Cresemba (isavuconazonium sulfate) to treat aspergillosis and invasive mucormycosis (also known as zygomycosis). The prodrug for ...
Pharmaceutical Business Review - Sun, 08 Mar 2015 23:48
|Astellas Cresemba Gains FDA Approval, Under Review in EU|
Zacks.com - Mon, 09 Mar 2015 12:41
|US approval for Astellas' new antifungal drug Cresemba|
PMLiVE - Mon, 09 Mar 2015 03:37
|Astellas' Cresemba Gains FDA Approval, Under Review in EU - Analyst Blog|
Nasdaq - Mon, 09 Mar 2015 14:39
|Basilea reports U.S. FDA approval of isavuconazole for the treatment of ...|
GlobeNewswire (press release) - Fri, 06 Mar 2015 14:14
|FDA approves Astellas' CRESEMBA for treatment of invasive aspergillosis ...|
News-Medical.net - Sun, 08 Mar 2015 05:03
|Flying debris from devastating Joplin tornado causes deadly 'zygomycosis ...|
He said three or four of them died and zygomycosis was a factor - but had previously only seen two cases of the infection in his whole career. 'It's definitely quite striking,' the Freeman Health System physician said. 'To have so many cases of this is ...
Daily Mail - Fri, 10 Jun 2011 08:34
|Aggressive Fungal Infection Striking Joplin Victims|
ABC News - Fri, 10 Jun 2011 11:31
|Potentially fatal infection strikes Joplin tornado victims|
Telegraph.co.uk - Thu, 09 Jun 2011 17:42
|Rare, Aggressive Fungus Strikes Joplin Tornado Victims|
KMOX.com - Fri, 10 Jun 2011 02:12
|Deadly Fungal Infection Strikes Victims of Joplin Tornado|
Fox News - Fri, 10 Jun 2011 06:38
|Basilea reports isavuconazole orphan drug designation for treatment of ...|
Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to isavuconazole for the treatment of zygomycosis (also known as mucormycosis), a life-threatening fungal ...
GlobeNewswire (press release) - Sun, 17 Nov 2013 22:22
|Lung Transplantation for Cystic Fibrosis|
Joseph P. Lynch III, MD; David M. Sayah, MD, PhD; John A. Belperio, MD; S. Sam Weigt, MD. Disclosures. Semin Respir Crit Care Med. 2015;36(2):299-320. Print. Abstract and Introduction; Lung Transplantation for Cystic Fibrosis · Lung Transplantation for ...
Medscape - Tue, 19 May 2015 20:56
|Isavuconazonium sulfate: A new azole for life-threatening fungal infections|
Isavuconazonium sulfate (Cresemba—Astellas) has received FDA approval to treat invasive aspergillosis and invasive mucormycosis (also known as zygomycosis). Aspergillosis and mucormycosis are fungal infections caused by the Aspergillus species and ...
American Pharmacists Association, pharmacist.com - Fri, 01 May 2015 14:02
|Matinas' Pipeline Is Ready To Shine (MTNB)|
... cryptococcosis (torulosis), North American blastomycosis, systemic candidiasis, coccidioido-mycosis, histoplasmosis, zygomycosis including mucormycosis due to susceptible species of the generaAbsidia, Mucor, and Rhizopus, and infections due to ...
Seeking Alpha - Thu, 16 Apr 2015 12:27
|Astellas Launches CRESEMBA® (isavuconazonium sulfate) in the United States ...|
... announced today that CRESEMBA® (isavuconazonium sulfate), the prodrug for isavuconazole, is now available in the United States for the treatment of adult patients with invasive aspergillosis and invasive mucormycosis (also known as zygomycosis).
PR Newswire (press release) - Mon, 27 Apr 2015 06:52
|CRESEMBA® (isavuconazonium sulfate) Data to be Presented at the European ...|
... Drug Administration (FDA) approved a New Drug Application (NDA) for the use of CRESEMBA in the United States for patients 18 years of age and older in the treatment of invasive aspergillosis and invasive mucormycosis (also known as zygomycosis).
PR Newswire (press release) - Thu, 23 Apr 2015 07:37